We are live on ! Find out more
WAM

Wealthspire Advisors (Maryland) Portfolio holdings

AUM $2.84B
1-Year Est. Return 10.91%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.91%
3 Year Est. Return
+31.7%
5 Year Est. Return
+89.89%
10 Year Est. Return
AUM
$1.49B
AUM Growth
+$123M
Cap. Flow
+$30.8M
Cap. Flow %
2.07%
Top 10 Hldgs %
42.99%
Holding
523
New
57
Increased
263
Reduced
145
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 11.74%
2 Financials 5.61%
3 Healthcare 5.04%
4 Consumer Discretionary 3.76%
5 Industrials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
151
Ecolab
ECL
$79.8B
$1.12M 0.08%
5,802
-267
-4% -$50.7K
QQQ icon
152
Invesco QQQ Trust
QQQ
$479B
$1.12M 0.08%
5,262
+100
+2% +$20K
VRSK icon
153
Verisk Analytics
VRSK
$24.7B
$1.11M 0.07%
7,453
+366
+5% +$54.2K
VGT icon
154
Vanguard Information Technology ETF
VGT
$147B
$1.11M 0.07%
36,328
-4,360
-11% -$125K
PYPL icon
155
PayPal
PYPL
$51.1B
$1.1M 0.07%
10,136
+731
+8% +$76.2K
SHW icon
156
Sherwin-Williams
SHW
$88.2B
$1.08M 0.07%
5,577
-258
-4% -$49.2K
ADP icon
157
Automatic Data Processing
ADP
$109B
$1.08M 0.07%
6,354
+212
+3% +$35.1K
EEM icon
158
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$1.07M 0.07%
23,754
+3
+0% +$129
TJX icon
159
TJX Companies
TJX
$179B
$1.06M 0.07%
17,440
+1,221
+8% +$72.2K
UPS icon
160
United Parcel Service
UPS
$87.7B
$1.05M 0.07%
9,007
+906
+11% +$107K
NVO
161
Novo Nordisk
NVO
$203B
$1.04M 0.07%
36,042
+530
+1% +$14.7K
PRVB
162
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.04M 0.07%
70,000
+7,500
+12% +$66.8K
LLY icon
163
Eli Lilly
LLY
$1.06T
$1.04M 0.07%
7,907
-173
-2% -$20.1K
HSIC icon
164
Henry Schein
HSIC
$9.83B
$1.04M 0.07%
15,536
-4
-0% -$265
APPN icon
165
Appian
APPN
$2.23B
$1.03M 0.07%
+27,016
New +$1.16M
PNC icon
166
PNC Financial Services
PNC
$101B
$1.02M 0.07%
6,405
+530
+9% +$79.6K
COO icon
167
Cooper Companies
COO
$14.3B
$1.02M 0.07%
12,644
-228
-2% -$17.2K
LH icon
168
Labcorp
LH
$25.6B
$1.01M 0.07%
6,982
-49
-0.7% -$7.07K
ASML icon
169
ASML
ASML
$655B
$1.01M 0.07%
3,413
-520
-13% -$140K
AVGO icon
170
Broadcom
AVGO
$2T
$1M 0.07%
31,750
+4,500
+17% +$137K
GD icon
171
General Dynamics
GD
$105B
$1M 0.07%
5,685
-104
-2% -$18.7K
TMO icon
172
Thermo Fisher Scientific
TMO
$214B
$997K 0.07%
3,068
+193
+7% +$58.5K
AXP icon
173
American Express
AXP
$231B
$996K 0.07%
8,002
-1,466
-15% -$175K
DLR icon
174
Digital Realty Trust
DLR
$71.3B
$995K 0.07%
8,309
-40
-0.5% -$4.92K
APH icon
175
Amphenol
APH
$210B
$993K 0.07%
36,704
+1,968
+6% +$50.2K

Similar funds

Wealthspire Advisors (Maryland)'s Q4 2019 Portfolio in Review

As of Q4 2019, Wealthspire Advisors (Maryland) held 523 positions worth $1.49B, up 9% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Wealthspire Advisors (Maryland)'s Q4 2019 filing shows 57 new, 263 increased, 145 reduced and 25 closed positions. Its largest new stake was PIMCO Income Strategy Fund: 603,378 shares worth $603K. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Wealthspire Advisors (Maryland)'s largest Q4 2019 buy was PIMCO Income Strategy Fund: 603,378 shares worth $603K.
  • Wealthspire Advisors (Maryland) added most to Schwab US Dividend Equity ETF in Q4 2019, an estimated $13.2M increase.
  • Wealthspire Advisors (Maryland)'s biggest Q4 2019 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $10.2M.
  • Wealthspire Advisors (Maryland) fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $817K.
  • Wealthspire Advisors (Maryland)'s ten largest holdings make up 43% of its $1.49B portfolio in Q4 2019.
  • Wealthspire Advisors (Maryland) opened 57 new positions and closed 25 in Q4 2019.
  • Wealthspire Advisors (Maryland)'s portfolio value rose 9% quarter-over-quarter to $1.49B.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q4 2019, filed 14 Feb 2020.